Clinical Trials

1 enrolled 1 chart

Hematologic Neoplasms

NCT04673175 2026-01-21

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Phase 4 Terminated

17 enrolled 20 charts

Pneumonia, Pseudomonas Infections, Bacteremia, Gram-Negative Bacterial Infections, Hematologic Neoplasms

NCT04379518 2026-01-13

Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients

4 enrolled 30 charts

Hematologic Neoplasms

NCT03870750 2026-01-12

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Phase 2/3 Terminated

458 enrolled

Hematologic Neoplasms

NCT06018506 2025-11-21

A Phase I Study of BR108 in Hematological Malignancies

Phase 1 Terminated

8 enrolled

Hematologic Neoplasms

NCT04874194 2025-11-03

Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1

MyeloidOther hematologic neoplasm

24 enrolled 15 charts

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT03320642 2025-10-21

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Phase 1 Terminated

84 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT05579769 2025-10-02

Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

3 enrolled 10 charts

LymphoidOther hematologic neoplasm

Hematologic Neoplasms

NCT04473937 2025-09-24

Radiation Post-CAR T in Refractory Lymphoma

Phase NA Terminated

3 enrolled 9 charts

Lymphoma, Hematologic Neoplasms

NCT00507572 2025-08-13

Collection of Outcomes Data for Pregnant Patients With Cancer

Terminated

313 enrolled

Phase EARLY_PHASE1 Terminated

Hematologic Neoplasms

NCT03579446 2025-08-03

Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer

43 enrolled

Neoplasm Metastasis, Hematologic Neoplasms

NCT02849886 2025-07-09

Side_by_Cide

2 enrolled

Graft vs Host Disease, Hematologic Neoplasms

NCT03743480 2025-06-25

EPC-EMA1

Phase NA Terminated

15 enrolled

Neoplasms, Hematologic Neoplasms

NCT06108739 2025-06-03

ATG Plus Low-dose PT-Cy for GVHD Prevention

Phase 3 Terminated

66 enrolled

Hematologic Neoplasms

NCT01350258 2025-05-31

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

LymphoidMyeloidOther hematologic neoplasmPlasma cell

8 enrolled 8 charts

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT04752163 2025-05-23

DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

LymphoidMyeloidOther hematologic neoplasm

17 enrolled 15 charts

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04347226 2025-05-22

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

43 enrolled 14 charts

COVID-19, Coronavirus Infections, Hematologic Neoplasms

NCT01532635 2025-05-04

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives